These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12637885)

  • 1. [Value of MRI in symptomatic patients treated with tamoxifen].
    Taïeb S; Ceugnart L; Chevalier A; Cabaret V; Leblanc E; Fournier C; Besson P
    J Radiol; 2003 Jan; 84(1):33-9. PubMed ID: 12637885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation.
    Ascher SM; Johnson JC; Barnes WA; Bae CJ; Patt RH; Zeman RK
    Radiology; 1996 Jul; 200(1):105-10. PubMed ID: 8657895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
    Hricak H; Finck S; Honda G; Göranson H
    AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI evaluation of myometrial invasion by endometrial carcinoma. Comparison between fast-spin-echo T2w and coronal-FMPSPGR Gadolinium-Dota-enhanced sequences.
    Nasi F; Fiocchi F; Pecchi A; Rivasi F; Torricelli P
    Radiol Med; 2005 Sep; 110(3):199-210. PubMed ID: 16200042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.
    Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H
    J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal uterine cavity: differential diagnosis with MR imaging.
    Imaoka I; Sugimura K; Masui T; Takehara Y; Ichijo K; Naito M
    Magn Reson Imaging; 1999 Dec; 17(10):1445-55. PubMed ID: 10609993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign and malignant diseases of the endometrium.
    Chaudhry S; Reinhold C; Guermazi A; Khalili I; Maheshwari S
    Top Magn Reson Imaging; 2003 Aug; 14(4):339-57. PubMed ID: 14578778
    [No Abstract]   [Full Text] [Related]  

  • 10. Endometrial polyps: MR imaging features.
    Hase S; Mitsumori A; Inai R; Takemoto M; Matsubara S; Akamatsu N; Fujisawa M; Joja I; Sato S; Kanazawa S
    Acta Med Okayama; 2012; 66(6):475-85. PubMed ID: 23254582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of endometrial pathologies collected by hysteroscopy and hysterectomy in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Azaria R; Bernheim J; Tepper R; Sharony R; Beyth Y
    Eur J Gynaecol Oncol; 2000; 21(4):418-22. PubMed ID: 11055500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial cancer in polyps associated with tamoxifen use.
    Ramondetta LM; Sherwood JB; Dunton CJ; Palazzo JP
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):340-1. PubMed ID: 9988797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
    Hann LE; Gretz EM; Bach AM; Francis SM
    AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding.
    Fotiou S; Tserkezoglou A; Hadjieleftheriou G; Apostolikas N; Karydas I; Stravolemos K
    Anticancer Res; 1998; 18(1B):625-9. PubMed ID: 9584044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging.
    Yamashita Y; Mizutani H; Torashima M; Takahashi M; Miyazaki K; Okamura H; Ushijima H; Ohtake H; Tokunaga T
    AJR Am J Roentgenol; 1993 Sep; 161(3):595-9. PubMed ID: 8352114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen-induced uterine abnormalities: the role of imaging.
    Ascher SM; Imaoka I; Lage JM
    Radiology; 2000 Jan; 214(1):29-38. PubMed ID: 10644098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does tamoxifen induce endometrial hyperplasia, carcinoma and polyps?
    van den Bosch T; Vandendael A
    S Afr Med J; 1994 Jun; 84(6):367-8. PubMed ID: 7740401
    [No Abstract]   [Full Text] [Related]  

  • 19. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
    Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen and endometrial pathologies: a prospective study.
    Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H
    Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.